The choice of chemo-or immuno-therapy for muscle-invasive bladder cancer (MIBC) patients
remains contentious. Podoplanin is newly identified as an immune checkpoint which …

Simple Summary Bladder cancer is a type of malignant tumor. Eighty percent of patients are
diagnosed with non-muscle-invasive bladder cancer (NMIBC), which has a good prognosis …

The edible Rosa hybrida (RH) petal is utilized in functional foods and cosmetics. Although
the biological function of RH petal extract is known, mechanism of action studies involving …

Purpose Many studies identified that the preoperative neutrophil-to-lymphocyte ratio (PNLR)
was associated with patient prognosis in non-muscle-invasive bladder cancer (NMIBC). We …

The primary role of immunotherapy for bladder cancer is to treat superficial transitional cell
carcinomas (ie, carcinoma in situ, Ta, and T1). Immunotherapy in the form of bacille …

Background: Abnormalities in the mitochondrial energy metabolism pathways are closely
related to the occurrence and development of many cancers. Furthermore, abnormal genes …

Cuproptosis is a type of programmed cell death involving copper, distinct from other cell
death such as apoptosis, necroptosis, and ferroptosis. The burgeoning field of …

Bladder cancer is one of the most commonly diagnosed cancers worldwide, especially in
males. Current therapeutic interventions, including surgery, radiation therapy …

Abstract Background Bladder cancer (BCa) shows its potential immunogenity in current
immune-checkpoint inhibitor related immunotherapies. However, its therapeutic effects are …

Background Bladder cancer (BLCA) is a common malignant tumor of urinary system and
prognostic biomarkers are needed for better clinical decision-making and patient …